6513例COVID-19患者静脉血栓栓塞症发生率:回顾性研究
该回顾性研究检索了新奥尔良某医疗系统2020年3月1日至5月1日期间6153例确诊SARS-CoV-2感染的患者电子病历,其中2748例住院、3405例仅急诊就诊。住院患者VTE发生率为3.1%(86例),机械通气患者为7.2%(45/637),未发现异常高的VTE风险,支持传统VTE预防策略。
要点
- 住院COVID-19患者VTE发生率为3.1%,未显示异常升高。
- 机械通气患者VTE发生率为7.2%,高于总体住院患者。
- 出院存活患者随访中VTE发生率仅0.14%。
核心结论
- 在6153例住院或急诊治疗的COVID-19患者中,未发现异常高的VTE风险证据。
- 研究结果支持对COVID-19患者采用传统的VTE一级预防策略,直至前瞻性对照试验提供进一步证据。
研究设计与样本
- 回顾性研究,检索新奥尔良某医疗系统电子健康记录,纳入2020年3月1日至5月1日PCR确诊SARS-CoV-2感染且住院或急诊治疗并出院的患者。
- 共纳入6153例患者,其中2748例住院,3405例仅急诊就诊;637例需机械通气,206例需肾脏替代治疗。
主要发现
- 住院患者总体死亡率为24.5%,VTE发生于86例(3.1%)。
- 637例机械通气患者中45例发生VTE(7.2%)。
- 2075例住院后存活出院患者中,中位随访14.6天后3例诊断VTE(0.14%)。
临床怎么用
- 对于COVID-19患者,可采用传统的VTE预防方法,无需因疫情而常规升级抗凝策略。
- 应关注机械通气等重症患者的VTE风险,但总体发生率不支持过度抗凝。
局限性
- 回顾性研究设计,依赖电子病历行政查询,可能存在漏诊或误诊。
- 单中心医疗系统数据,结果外推需谨慎。
- 随访时间较短,中位随访14.6天,可能低估出院后VTE事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appear to be at increased risk for venous thromboembolism (VTE), especially if they become critically ill with COVID-19. Some centers have reported very high rates of thrombosis despite anticoagulant prophylaxis. The electronic health record (EHR) of a New Orleans-based health system was searched for all patients with polymerase chain reaction-confirmed SARS-CoV-2 infection who were either admitted to hospital or treated and discharged from an emergency department between 1 March 2020 and 1 May 2020. From this cohort, patients with confirmed VTE (either during or after their hospital encounter) were identified by administrative query of the EHR.: Between 1 March 2020 and 1 May 2020, 6153 patients with COVID-19 were identified; 2748 of these patients were admitted, while 3405 received care exclusively through the emergency department. In total, 637 patients required mechanical ventilation and 206 required renal replacement therapy. Within the hospitalized cohort, the overall mortality rate was 24.5% and VTE occurred in 86 patients (3.1%). In the 637 patients who required mechanical ventilation at some point during their hospital stay, 45 developed VTE (7.2%). After a median follow-up of 14.6 days, VTE had been diagnosed in 3 of the 2075 admitted who were discharged alive (0.14%). Among 6153 patients with COVID-19 who were hospitalized or treated in emergency departments, we did not find evidence of unusually high VTE risk. Pending further evidence from prospective, controlled trials, our findings support a traditional approach to primary VTE prevention in patients with COVID-19.
引用
- Hill JB, Garcia D, Crowther M, et al. Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study. Blood Adv. 2020. PMID: 33137202. doi:10.1182/bloodadvances.2020003083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。